Skin-Cap OTC psoriasis treatment contains undeclared corticosteroids -- FDA alert.
This article was originally published in The Tan Sheet
Executive Summary
SKIN-CAP OTC PSORIASIS PRODUCT CONTAINS UNDECLARED CORTICOSTEROIDS, FDA states in an Aug. 8 consumer alert. The agency says its analysis of Skin-Cap has shown the topical product contains "prescription levels of a potent topical steroid, clobetasol propionate." Individuals using the product are advised to "immediately contact their health care providers." Skin-Cap is manufactured by Cheminova International in Madrid, Spain and imported to the U.S. through several distributors.